Home / Stocks / GMED

GMED insider trading

GLOBUS MEDICAL INC — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-19ZARRILLI STEPHEN T
Director
Sold25,000$87.04$2.2M
2026-06-09Davidar David D
Director
Sold25,000$80.76$2.0M
2026-02-27Huller Kelly
EVP, GC, Corporate Secretary
Sold20,000$94.50$1.9M
2025-12-03Kline Kyle
Senior Vice President, CFO
Sold18,542$90.00$1.7M
2025-11-13ZARRILLI STEPHEN T
Director
Sold25,000$84.29$2.1M
2025-11-13Davidar David D
Director
Sold25,000$86.00$2.1M
2025-01-14Pfeil Keith W
COO, CFO
Sold12,501$88.17$1.1M
2024-11-25Davidar David D
Director
Sold26,488$85.00$2.3M
2024-11-25Lemaitre Dan
Director
Sold13,278$85.00$1.1M
2024-11-25Scavilla Daniel T
President, CEO
Sold130,000$85.00$11.1M
2024-11-08Scavilla Daniel T
President, CEO
Sold60,000$80.02$4.8M
2024-10-18Davidar David D
Director
Sold50,000$75.04$3.8M
2024-09-17RHOADS ANN D
Director
Sold15,000$70.36$1.1M
2024-09-17Davidar David D
Director
Sold25,000$70.46$1.8M

See GMED on the chart

Every insider buy and sell for GMED plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.